Top compounds associated with response to TMED7-TICAM2


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.2 4e-07
mRNA GW-405833 CTRPv2 pan-cancer AAC -0.2 5e-07
mRNA ISOX:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.2 5e-07
mRNA tipifarnib CTRPv2 pan-cancer AAC -0.18 6e-07
mRNA SB-743921 CTRPv2 pan-cancer AAC -0.19 6e-07
mRNA GSK461364 CTRPv2 pan-cancer AAC -0.18 9e-07
mRNA SCH-79797 CTRPv2 pan-cancer AAC -0.2 1e-06
mRNA barasertib CTRPv2 pan-cancer AAC -0.18 1e-06
mRNA GMX-1778 CTRPv2 pan-cancer AAC -0.2 1e-06
mRNA Gemcitabine CTRPv2 pan-cancer AAC -0.18 1e-06
Download CSV